{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:07:08Z","timestamp":1792069628846,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.dld.2026.05.010","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:42:48Z","timestamp":1781300568000},"page":"1027-1036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Statins in chronic liver disease and its complications: An umbrella review and meta-analysis of systematic reviews"],"prefix":"10.1016","volume":"58","author":[{"given":"Filippo","family":"Cattazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Cinque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5499-4778","authenticated-orcid":false,"given":"Vincenzo Di","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6012-1524","authenticated-orcid":false,"given":"Marco","family":"Vicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2391-1689","authenticated-orcid":false,"given":"Mirko","family":"Zoncap\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-8486","authenticated-orcid":false,"given":"Leonardo Antonio","family":"Natola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sacerdoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6958-927X","authenticated-orcid":false,"given":"Rosa","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-4176","authenticated-orcid":false,"given":"Andrea","family":"Dalbeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.dld.2026.05.010_bib0001","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.05.010_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.dld.2026.05.010_bib0003","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2011.08.016","article-title":"Yes! statins can be given to liver patients","volume":"56","author":"Bader","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2026.05.010_bib0004","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhep.2018.07.019","article-title":"Old drugs as new therapy for liver diseases?","volume":"70","author":"Pose","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2026.05.010_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115644","article-title":"Anti-fibrotic effects of statin drugs: a review of evidence and mechanisms","volume":"214","author":"Dolivo","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.dld.2026.05.010_bib0006","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tcm.2005.07.002","article-title":"Toward immunomodulatory and anti-inflammatory properties of statins","volume":"15","author":"Arnaud","year":"2005","journal-title":"Trends Cardiovasc Med"},{"issue":"6257","key":"10.1016\/j.dld.2026.05.010_bib0007","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.dld.2026.05.010_bib0008","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/rho-kinase and activation of endothelial nitric oxide synthase","volume":"46","author":"Trebicka","year":"2007","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.dld.2026.05.010_bib0009","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.dld.2026.05.010_bib0010","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0168-8278(03)00051-5","article-title":"Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells","volume":"38","author":"Rombouts","year":"2003","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.dld.2026.05.010_bib0011","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/ajg.2017.170","article-title":"Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis","volume":"112","author":"Kamal","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.dld.2026.05.010_bib0012","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MCG.0000000000001478","article-title":"Efficacy and safety of Statin for hepatocellular carcinoma prevention among chronic liver disease patients: a systematic review and meta-analysis","volume":"55","author":"Wong","year":"2021","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.dld.2026.05.010_bib0013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5152\/tjg.2020.19656","article-title":"Statins in Hepatitis B or C patients is associated with reduced hepatocellular carcinoma risk: a systematic review and meta-analysis","volume":"33","author":"Li","year":"2022","journal-title":"Turk J Gastroenterol"},{"issue":"10","key":"10.1016\/j.dld.2026.05.010_bib0014","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/pds.3685","article-title":"Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden","volume":"23","author":"Bj\u00f6rkhem-Bergman","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.dld.2026.05.010_bib0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MEG.0000000000002517","article-title":"Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"35","author":"Zhang","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2026.05.010_bib0016","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jclinepi.2013.11.007","article-title":"Systematic review finds overlapping reviews were not mentioned in every other overview","volume":"67","author":"Pieper","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.dld.2026.05.010_bib0017","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/1468-0009.12210","article-title":"The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses","volume":"94","author":"Ioannidis","year":"2016","journal-title":"Milbank Q"},{"key":"10.1016\/j.dld.2026.05.010_bib0018","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.dld.2026.05.010_bib0019","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jclinepi.2013.11.007","article-title":"Systematic review finds overlapping reviews were not mentioned in every other overview","volume":"67","author":"Pieper","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"7414","key":"10.1016\/j.dld.2026.05.010_bib0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7109","key":"10.1016\/j.dld.2026.05.010_bib0021","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2026.05.010_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104392","article-title":"Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study","volume":"87","author":"Ayada","year":"2023","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.dld.2026.05.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70326","article-title":"Statin therapy and portal pressure reduction in cirrhosis: A systematic review and meta-analysis","volume":"45","author":"Abdulrazzak","year":"2025","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.dld.2026.05.010_bib0024","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.clnu.2022.08.001","article-title":"Statins' efficacy in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"41","author":"Boutari","year":"2022","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.dld.2026.05.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101816","article-title":"Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis","volume":"46","author":"Fatima","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2026.05.010_bib0026","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12876-019-1147-1","article-title":"Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis","volume":"19","author":"Gu","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"10.1016\/j.dld.2026.05.010_bib0027","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cgh.2017.04.039","article-title":"Statin use and risk of cirrhosis and related complications in patients with chronic liver diseases: A systematic review and meta-analysis","volume":"15","author":"Kim","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2026.05.010_bib0028","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.clinre.2017.07.004","article-title":"Statin use and virus-related cirrhosis: A systemic review and meta-analysis","volume":"41","author":"Ma","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2026.05.010_bib0029","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12876-021-01704-w","article-title":"A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis","volume":"21","author":"Sung","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2026.05.010_bib0030","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/07853890.2021.1956686","article-title":"Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants","volume":"53","author":"Vahedian-Azimi","year":"2021","journal-title":"Ann Med"},{"key":"10.1016\/j.dld.2026.05.010_bib0031","first-page":"1","article-title":"A meta-analysis of statin use and risk of hepatocellular carcinoma","volume":"2022","author":"Wang","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.dld.2026.05.010_bib0032","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1097\/MCG.0000000000001732","article-title":"Simvastatin is efficacious in treating cirrhosis: A meta-analysis","volume":"56","author":"Zhang","year":"2022","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2026.05.010_bib0033","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/apt.17371","article-title":"Meta-analysis: chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin","volume":"57","author":"Zeng","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.dld.2026.05.010_bib0034","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MEG.0000000000000867","article-title":"The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis","volume":"29","author":"Zheng","year":"2017","journal-title":"Eur J Gastroenterol Hepatology"},{"key":"10.1016\/j.dld.2026.05.010_bib0035","doi-asserted-by":"crossref","unstructured":"Ramos-Tovar E, Muriel P. Molecular mechanisms that link oxidative stress, inflammation, and fibrosis in the liver. Antioxidants (Basel). 2020 Dec 15;9(12):1279. doi: 10.3390\/antiox9121279. PMID: 33333846; PMCID: PMC7765317.","DOI":"10.3390\/antiox9121279"},{"key":"10.1016\/j.dld.2026.05.010_bib0036","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1746.2006.04570.x","article-title":"Mitochondrial glutathione: hepatocellular survival-death switch","volume":"21","author":"Garcia-Ruiz","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2026.05.010_bib0037","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/153537020422900701","article-title":"Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention","volume":"229","author":"Mo","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"issue":"11","key":"10.1016\/j.dld.2026.05.010_bib0038","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc3151","article-title":"Targeting protein prenylation for cancer therapy","volume":"11","author":"Berndt","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.dld.2026.05.010_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5537737","article-title":"A novel ruthenium-fluvastatin complex downregulates SNCG expression to modulate breast carcinoma cell proliferation and apoptosis via activating the PI3K\/akt\/mTOR\/VEGF\/MMP9 pathway","volume":"2021","author":"Liang","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"16","key":"10.1016\/j.dld.2026.05.010_bib0040","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1128\/MCB.00105-13","article-title":"LIM-only protein FHL2 activates NF-\u03bab signaling in the control of liver regeneration and hepatocarcinogenesis","volume":"33","author":"Dahan","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.dld.2026.05.010_bib0041","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2174\/0929867331666230918114451","article-title":"Statins and portal hypertension: A systematic review and meta-analysis of randomized controlled trials","volume":"32","author":"Jamialahmadi","year":"2025","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.dld.2026.05.010_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106367","article-title":"SACRED: effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: statins and cirrhosis: reducing events of decompensation","volume":"104","author":"Kaplan","year":"2021","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"10.1016\/j.dld.2026.05.010_bib0043","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2468-1253(19)30320-6","article-title":"Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"5","author":"Pose","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826007498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826007498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:26:12Z","timestamp":1784719572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826007498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1590865826007498"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.05.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins in chronic liver disease and its complications: An umbrella review and meta-analysis of systematic reviews","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}